Journals / Erciyes Tıp Dergisi / 2006 / Cilt: 28 - Sayı: 4

Diagnosis and therapy of erectile dysfunction in man

Erkekte erektil işlev bozukluğu tanı ve tedavisi

Pages
220–225
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the options in the diagnosis and treatment of ED are discussed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The prevalence of erectile dysfunction (ED) increases with age.
📊
Key Findings & Data:These drugs are phosphodiesterase type V enzyme inhibitors and have decreased the use of other more invasive treatment options.
💡
Conclusion & Impact:In this review, the options in the diagnosis and treatment of ED are discussed
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The prevalence of erectile dysfunction (ED) increases with age. There are several options in the diagnosis and treatment of the patients. Some patients with occult cardiovascular diseases might appear with only the complaint of ED. The patients are reluctant to tell their sexual problems. The purpose of healthcare providers should be to find out and direct the patients with ED which is an issue capable of decreasing quality of life. The treatment has become easier with the widespread use of some new oral medications. These drugs are phosphodiesterase type V enzyme inhibitors and have decreased the use of other more invasive treatment options. Optimal treatment of the patients might increase the quality of life of both the male and his partner. In this review, the options in the diagnosis and treatment of ED are discussed

Özet

Erektil işlev bozukluğu yaşlandıkça sıklığı artan bir rahatsızlıktır. Bu olguların tanı ve tedavisinde bir çok yaklaşım bulunmaktadır. Erektil işlev bozukluğu özellikle kalp ve damar rahatsızlıklarının ön belirtisi olarak karşımıza çıkabilir. Hastalar cinsel sorunları hakkında konuşmakta zorlanabilmektedir. Sağlıkçıların görevi yaşam kalitesini belirgin şekilde bozabilen bu durumu açığa çıkarabilmek ve hastaları yönlendirebilmek olmalıdır. Günümüzde ağızdan kullanılabilen ajanların yaygınlaşmasıyla tedavi nispeten kolaylaşmıştır. Bu ilaçlar fosfodiesteraz tip V enzim inhibitörleridir ve daha invaziv olan diğer tedavi yöntemlerinin uygulanmasını azaltmıştır. Hastaların uygun bir şekilde tedavi edilmesi bireyin ve çiftin yaşam kalitesini artırabilir. Bu derlemede erektil işlev bozukluğunun tanı ve tedavisinde kullanılan yaklaşımlar değerlendirilmiştir.

🔖

Cite This Article

DEMİRTAŞ, A., EKMEKÇİOĞLU, O. (2022). Diagnosis and therapy of erectile dysfunction in man. Erciyes Tıp Dergisi, Cilt: 28 - Sayı: 4, 220–225. https://ajindex.com/articles/502787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: report of the nomenclature committee of the International Society of Impotence Research. Int J Imp Res 1999; 111:41-43
  2. Lobo JR, Nehra A. Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors. Urol Clin North Am 2005; 32:447-455
  3. Russell S, Nehra A. The physiology of erectile dysfunction.Herz 2003; 28:277-283
  4. Abdel-Hamid I. Mechanisms of vasculagenic erectile dysfunction after kidney transplantation. BJU Int 2004;94:497-500
  5. Sullivan ME, Thompson CS, Dashwood MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999;43:658-665
  6. Rabbani F, Stapleton AMF, Kattan W, et al. Factors predicting recovery of erections after radical prostatectomy.J Urol 2000; 164:1929-1934
  7. Leliefeld HHJ, Stovelaar HJ, McDonnell JM. Sexual function after various treatments for benign prostatic hyperplasia. BJU Int 2002; 89:208-213
  8. Feldman HA, Goldstein I, Hatzichristou DG, et al.Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994:151:54-61
  9. Akkus E, Kadioglu A, Esen A, et al. Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41:298-304
  10. Rosen RC, Wing R, Schneider S, and Gendrano III N.Epidemiology of erectile dysfunction: the role of medical comorbidities and lyfestyle factors. Urol Clin North Am 2005; 32:403-418
  11. Levine LA, Lenting EL. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am. 1995;22:775-788
  12. Montorsi F, Salonia A, Zanoni M, Pompa P, Cestari A,Guazzoni G, Barbieri L, Rigatti P. Current status of local penile therapy. Int J Impot Res. 2002;14 Suppl 1:S70-81
  13. Ekmekçioğlu O, Demirci D, Yılmaz B, Tatlışen A. Erektil işlev bozukluğunda intrakavernöz enjeksiyon tedavisi. Türk Üroloji Dergisi 2002; 28:181-186
  14. Aversa A, Bruzziches R, Spera G. Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited. Int J Androl. 2005; 28 Suppl 2:61-63
  15. Broderick GA. Evidence based assessment of erectile dysfunction. Int J Impot Res. 1998;10 Suppl 2:S64-73
  16. Miller TA. Diagnostic evaluation of erectile dysfunction.Am Fam Physician. 2000; 61:95-104
  17. Gresser U, Gleiter CH. Erectile dysfunction: comparison of effi